Patents by Inventor Synthia Mellon

Synthia Mellon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapy for treatment of chronic degenerative brain diseases and nervous system injury
    Patent number: 9597336
    Abstract: In one aspect, the present invention provides neuroactive steroids for use in the treatment of nervous system disorders, degenerative brain diseases and congenital storage diseases. In a second aspect, the invention provides neuroactive steroids in combination with a Liver X Receptor (LXR) ligand to effect treatment of a nervous system condition.
    Type: Grant
    Filed: October 24, 2013
    Date of Patent: March 21, 2017
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: Synthia Mellon
  • NOVEL THERAPY FOR TREATMENT OF CHRONIC DEGENERATIVE BRAIN DISEASES AND NERVOUS SYSTEM INJURY
    Publication number: 20140148427
    Abstract: In one aspect, the present invention provides neuroactive steroids for use in the treatment of nervous system disorders, degenerative brain diseases and congenital storage diseases. In a second aspect, the invention provides neuroactive steroids in combination with a Liver X Receptor (LXR) ligand to effect treatment of a nervous system condition.
    Type: Application
    Filed: October 24, 2013
    Publication date: May 29, 2014
    Inventor: Synthia MELLON
  • Therapy for treatment of chronic degenerative brain diseases and nervous system injury
    Patent number: 8604011
    Abstract: In one aspect the present invention provides neuroactive steroids for use in the treatment of nervous system disorders, degenerative brain diseases and congenital storage diseases. In a second aspect the invention provides neuroactive steroids in combination with a Liver X Receptor (LXR) ligand to effect treatment of a nervous system condition.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: December 10, 2013
    Assignee: The Regents of the University of California
    Inventor: Synthia Mellon
  • Novel Therapy for Treatment of Chronic Degenerative Brain Diseases and Nervous System Injury
    Publication number: 20080269183
    Abstract: In one aspect the present invention provides neuroactive steroids for use in the treatment of nervous system disorders, degenerative brain diseases and congenital storage diseases. In a second aspect the invention provides neuroactive steroids in combination with a Liver X Receptor (LXR) ligand to effect treatment of a nervous system condition.
    Type: Application
    Filed: September 27, 2005
    Publication date: October 30, 2008
    Applicant: The Regents of the University of California
    Inventors: Synthia Mellon, Daniel S. Ory